BTVPUR AlSap 1

RSS

Withdrawn

This medicine's authorisation has been withdrawn

bluetongue-virus serotype-1 antigen
MedicineVeterinaryWithdrawn

Spanish is available via eTranslation, the European Commission's machine translation service.

Translate to Spanish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for BTVPUR AlSap 1 has been withdrawn at the request of the marketing-authorisation holder.

български (BG) (273.86 KB - PDF)

Ver

español (ES) (219.81 KB - PDF)

Ver

čeština (CS) (279.88 KB - PDF)

Ver

dansk (DA) (215.41 KB - PDF)

Ver

Deutsch (DE) (241.24 KB - PDF)

Ver

eesti (ET) (244.85 KB - PDF)

Ver

ελληνικά (EL) (281.98 KB - PDF)

Ver

français (FR) (242.72 KB - PDF)

Ver

italiano (IT) (215.09 KB - PDF)

Ver

latviešu (LV) (257.92 KB - PDF)

Ver

lietuvių (LT) (242.99 KB - PDF)

Ver

magyar (HU) (257.59 KB - PDF)

Ver

Malti (MT) (287.39 KB - PDF)

Ver

Nederlands (NL) (215.61 KB - PDF)

Ver

polski (PL) (262.68 KB - PDF)

Ver

português (PT) (215.81 KB - PDF)

Ver

română (RO) (264.84 KB - PDF)

Ver

slovenčina (SK) (263.85 KB - PDF)

Ver

slovenščina (SL) (271.89 KB - PDF)

Ver

suomi (FI) (214.4 KB - PDF)

Ver

svenska (SV) (215.45 KB - PDF)

Ver

Product information

български (BG) (1.59 MB - PDF)

Ver

español (ES) (959.08 KB - PDF)

Ver

čeština (CS) (1.31 MB - PDF)

Ver

dansk (DA) (976.46 KB - PDF)

Ver

Deutsch (DE) (1.05 MB - PDF)

Ver

eesti (ET) (962.08 KB - PDF)

Ver

ελληνικά (EL) (1.63 MB - PDF)

Ver

français (FR) (969.67 KB - PDF)

Ver

hrvatski (HR) (995.44 KB - PDF)

Ver

italiano (IT) (409.73 KB - PDF)

Ver

latviešu (LV) (588.19 KB - PDF)

Ver

lietuvių (LT) (480.92 KB - PDF)

Ver

magyar (HU) (1.31 MB - PDF)

Ver

Malti (MT) (596.85 KB - PDF)

Ver

Nederlands (NL) (355.82 KB - PDF)

Ver

polski (PL) (595.12 KB - PDF)

Ver

português (PT) (421.48 KB - PDF)

Ver

română (RO) (479.93 KB - PDF)

Ver

slovenčina (SK) (582.8 KB - PDF)

Ver

slovenščina (SL) (563.67 KB - PDF)

Ver

suomi (FI) (942.5 KB - PDF)

Ver

svenska (SV) (419.01 KB - PDF)

Ver

Íslenska (IS) (1.21 MB - PDF)

Ver

norsk (NO) (410.45 KB - PDF)

Ver
Latest procedure affecting product information:R/0005
08/09/2015

български (BG) (237.24 KB - PDF)

Ver

español (ES) (179.61 KB - PDF)

Ver

čeština (CS) (214.8 KB - PDF)

Ver

dansk (DA) (168.71 KB - PDF)

Ver

Deutsch (DE) (181.32 KB - PDF)

Ver

eesti (ET) (216.18 KB - PDF)

Ver

ελληνικά (EL) (224.9 KB - PDF)

Ver

français (FR) (168.45 KB - PDF)

Ver

hrvatski (HR) (203.36 KB - PDF)

Ver

italiano (IT) (166.05 KB - PDF)

Ver

latviešu (LV) (222.44 KB - PDF)

Ver

lietuvių (LT) (215.2 KB - PDF)

Ver

magyar (HU) (208.44 KB - PDF)

Ver

Malti (MT) (226.37 KB - PDF)

Ver

Nederlands (NL) (169.29 KB - PDF)

Ver

polski (PL) (215.44 KB - PDF)

Ver

português (PT) (180.94 KB - PDF)

Ver

română (RO) (212.26 KB - PDF)

Ver

slovenčina (SK) (211.23 KB - PDF)

Ver

slovenščina (SL) (210.68 KB - PDF)

Ver

suomi (FI) (168.59 KB - PDF)

Ver

svenska (SV) (168.12 KB - PDF)

Ver

Íslenska (IS) (171.81 KB - PDF)

Ver

norsk (NO) (166.89 KB - PDF)

Ver

Product details

Name of medicine
BTVPUR AlSap 1
Active substance
bluetongue-virus serotype-1 antigen
International non-proprietary name (INN) or common name
bluetongue-virus serotype-1 antigen
Species
  • Sheep
  • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) code
QI04AA02

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotype 1.

Onset of immunity has been demonstrated three weeks after the primary vaccination course. The duration of immunity for cattle and sheep is one year after the primary vaccination course.

Authorisation details

EMA product number
EMEA/V/C/002230
Marketing authorisation holder
Merial

29 Avenue Tony Garnier
69007 Lyon
France

Marketing authorisation issued
17/12/2010
Revision
4

Assessment history

This page was last updated on

Share this page